发明名称 Sulphated hyaluronic acid for treating degenerative osteoarthritis
摘要 This invention relates to oral and intra-articular formulations based on sulphated hyaluronic acid which are effective in the treatment of degenerative osteoarthritis.
申请公布号 US8765714(B2) 申请公布日期 2014.07.01
申请号 US201213410227 申请日期 2012.03.01
申请人 Fidia Farmaceutici S.p.A. 发明人 Callegaro Lanfranco;Renier Davide
分类号 A61K31/727;A01N43/04;A61K31/715 主分类号 A61K31/727
代理机构 Birch, Stewart, Kolasch & Birch, LLP 代理人 Birch, Stewart, Kolasch & Birch, LLP
主权项 1. A method for treating cartilage damage caused by degenerative osteoarthritis presenting without plasma infiltrates of cartilage comprising orally administering to a patient in need thereof an effective degenerative osteoarthritis treatment amount of a sulphated hyaluronic acid (HAS), wherein the hyaluronic acid used to prepare said HAS has a molecular weight between 100,000 and 230,000 D, and wherein said HAS has a degree of sulphation between 0.5 and 3.5, and where said administration is effective to increase within a joint exhibiting said cartilage damage the amount of the material that constitutes the scaffolding of the cartilage matrix.
地址 Abano Terme IT